Bias in cancer treatment for single people?
Did you know that being single or married is linked to the different treatments doctors prescribe for cancer patients? Is there any bias against unmarried cancer patients?
Single people may be given different treatment, and the treatment they receive is also generally less than that given to married people
A recent study in the New England Journal of Medicine has pointed to biases in the cancer treatments doctors offer: unmarried cancer patients are less likely to survive, possibly due in part to doctors' prejudices about single patients. This study was written by Professor Joan DelFattore of the University of Delaware when she was being treated for gallbladder cancer in 2011. At that time, her physician assessed her chances of successful treatment based on her marital status. She decided to share her views with friends and received a great deal of feedback, which led to her research.
Marital status has been used to classify treatment options for cancer patients since 1987. Doctors decide on treatment partly based on information about the patient's social relationships when making recommendations such as surgery, radiation therapy or chemotherapy.
The study, titled "Death by Stereotype? Cancer Treatment in Unmarried Patients", statistically analyzed 84 medical articles compiled from the database of the National Cancer Institute and found a correlation between marital status and the treatment patients received, according to the research method.
According to DelFattore, this is not shocking information; what is shocking is that this bias has been buried and has quietly persisted for 30 years in academic journals. DelFattore hopes her research will spark a conversation that raises awareness of the issue. Besides the risks caused by unintentional bias regarding race and gender, there is also bias regarding marital status in the treatment of cancer patients.
References:
Related Articles

FDA Approves Zidesamtinib (Jideytro) for ROS1+ Lung Cancer
The FDA has officially approved Zidesamtinib (Jideytro) for patients with ROS1+ non-small cell lung cancer previously treated with a TKI. Learn about its clinical efficacy now.
Read moreVIET HUY NEW YEAR KICKOFF 2026: RECHARGED AND READY FOR A BREAKTHROUGH 2026
Summary of the 2026 New Year kickoff article by VIET HUY Technological Scientific Equipment Co., Ltd: Event: The Viet Huy team officially returned to work after the Tet holiday with traditional activities such as exchanging New Year wishes, handshakes, and giving lucky red envelopes. Goals for 2026: Improve the quality of services and technical solutions. Accelerate innovation and creativity in scientific & biomedical equipment. Increase sustainable value for partners and customers. Message: A spirit of unity, a determination to break through, and a drive for success in the new year's projects. Contact information: Head office in Ho Chi Minh City, representative offices in Hanoi and Da Nang, and Hotline: 0913 605 512.
Read more
CERVICAL CANCER SCREENING - THE ROLE OF HPV TESTING
Cervical cancer is a dangerous and common disease in women. However, it can be effectively prevented through screening and HPV vaccination
Read moreNeed help choosing the right testing solution?
Viet Huy engineers are ready to help your laboratory choose the optimal technology.